Chembio Diagnostics DSO Ratio 2011-2026 | CEMI

Annual DSO Ratio Chembio Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
66.3	56.6	40.5	38.8	80.6	31.7	69.1	36.5	110	56.7	68.7	56.4

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
110	31.7	59.3

Quarterly DSO Ratio Chembio Diagnostics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	21.4	-	51.7	-	36.9	38.1	30.3	-	30	60.3	46.8	-	34.4	33.8	58.9	-	19.5	75.1	55.9	31.8	25.1	46.2	39.5	72.6	82.4	94.5	40.1	50	32.1	32.9	78.8	-	104	103	101	-	43.6	77.7	64.3	-	87.9	72.3	53.6	-	46.2	75.7	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
104	19.5	55.4

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	31.7	$ 19.89	10.93 %	$ 211 M	China
Agilent Technologies A	63.8	$ 120.39	2.46 %	$ 36.6 B	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
CareDx, Inc CDNA	51.5	$ 17.63	4.75 %	$ 939 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	94.7	$ 1.38	-4.83 %	$ 1.84 M	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	49.2	$ 24.37	3.57 %	$ 677 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	65	$ 179.31	0.54 %	$ 8.89 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Interpace Biosciences IDXG	66.9	$ 2.2	-	$ 9.73 M	USA
Danaher Corporation DHR	55.3	$ 198.61	1.4 %	$ 142 B	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	61.3	$ 130.32	2.65 %	$ 20.7 B	USA
Medpace Holdings MEDP	50.4	$ 520.0	3.74 %	$ 15 B	USA
Fulgent Genetics FLGT	77.4	$ 16.02	4.71 %	$ 484 M	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Guardant Health GH	46.1	$ 86.4	5.1 %	$ 10.8 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Myriad Genetics MYGN	52.3	$ 4.91	6.97 %	$ 455 M	USA
Anixa Biosciences ANIX	275	$ 2.88	1.05 %	$ 93.5 K	USA
Biomerica BMRA	57.7	$ 2.1	0.96 %	$ 4.82 M	USA
Senseonics Holdings SENS	10.3	$ 6.75	0.45 %	$ 282 M	USA
ICON Public Limited Company ICLR	68.5	$ 113.06	2.44 %	$ 9.33 B	Irlanda
NeoGenomics NEO	77.7	$ 8.35	4.38 %	$ 1.07 B	USA
Laboratory Corporation of America Holdings LH	52.9	$ 268.87	1.78 %	$ 22.4 B	USA
Neogen Corporation NEOG	66.6	$ 9.61	5.14 %	$ 2.08 B	USA
Lantheus Holdings LNTH	80.5	$ 82.74	1.31 %	$ 5.58 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 194.16	0.65 %	$ 21.6 B	USA
Natera NTRA	81.5	$ 214.64	6.31 %	$ 21.1 B	USA
ENDRA Life Sciences NDRA	7.11	$ 4.96	-4.43 %	$ 3.9 M	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
National Research Corporation NRC	29.4	$ 17.04	1.34 %	$ 381 M	USA
Organovo Holdings ONVO	79.8	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	4.66	-	-16.95 %	$ 1.54 M	USA